Matches in Wikidata for { <http://www.wikidata.org/entity/Q65391078> ?p ?o ?g. }
Showing items 1 to 34 of
34
with 100 items per page.
- Q65391078 description "clinical trial" @default.
- Q65391078 description "ensayu clínicu" @default.
- Q65391078 description "klinisch onderzoek" @default.
- Q65391078 description "клінічне випробування" @default.
- Q65391078 description "կլինիկական փորձարկում" @default.
- Q65391078 name "PROTECT-1: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function" @default.
- Q65391078 name "PROTECT-1: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function" @default.
- Q65391078 type Item @default.
- Q65391078 label "PROTECT-1: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function" @default.
- Q65391078 label "PROTECT-1: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function" @default.
- Q65391078 prefLabel "PROTECT-1: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function" @default.
- Q65391078 prefLabel "PROTECT-1: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function" @default.
- Q65391078 P1050 Q65391078-37B84CE4-0958-430D-AA7D-78F9D39D9F09 @default.
- Q65391078 P1132 Q65391078-B7C79EEA-5357-4F2F-B0AA-92E7D77F991B @default.
- Q65391078 P1476 Q65391078-776D0758-7ACE-450F-902B-0CD11563E52C @default.
- Q65391078 P2899 Q65391078-37CC05F4-7565-4838-A495-695FBA29F53D @default.
- Q65391078 P3098 Q65391078-CCBB149D-6832-49D3-ABE8-A06818CDA832 @default.
- Q65391078 P31 Q65391078-2769B59A-4FEF-441F-9DEB-27F405E7674D @default.
- Q65391078 P4844 Q65391078-3E0DD3EA-6101-4F68-A7AD-8E00DA3D7302 @default.
- Q65391078 P580 Q65391078-A96C7A40-53FB-40A3-A61D-B3FE82EAFFFD @default.
- Q65391078 P582 Q65391078-B18D351D-966B-4C8F-8190-7D76F3505970 @default.
- Q65391078 P6099 Q65391078-A0786B79-1AEB-4C40-96C4-C7F921181CB0 @default.
- Q65391078 P8363 Q65391078-395BBC03-31D2-4ED1-9D1F-3BDDD9F310D7 @default.
- Q65391078 P1050 Q181754 @default.
- Q65391078 P1132 "+932" @default.
- Q65391078 P1476 "A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Effects of KW-3902 Injectable Emulsion on Heart Failure Signs and Symptoms and Renal Function in Subjects With Acute Heart Failure Syndrome and Renal Impairment Who Are Hospitalized for Volume Overload and Require Intravenous Diuretic Therapy" @default.
- Q65391078 P2899 "+18" @default.
- Q65391078 P3098 "NCT00328692" @default.
- Q65391078 P31 Q30612 @default.
- Q65391078 P4844 Q7361410 @default.
- Q65391078 P580 "2006-08-01T00:00:00Z" @default.
- Q65391078 P582 "2009-07-01T00:00:00Z" @default.
- Q65391078 P6099 Q42824827 @default.
- Q65391078 P8363 Q78089383 @default.